Ventavis and Restasis drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ventavis (iloprost) and Restasis (cyclosporine). Common drug interactions include epistaxis among females and cardiac failure congestive among males.
The phase IV clinical study analyzes what interactions people have when they take Ventavis and Restasis. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.
What is Ventavis?
Ventavis has active ingredients of iloprost. eHealthMe is studying from 11,982 Ventavis users. Check the latest studies of Ventavis.
What is Restasis?
Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.
16 people who take Ventavis and Restasis together, and have interactions are studied.
What are the common drug interactions of Ventavis and Restasis, by gender? *:
female:
- Epistaxis (bleed from the nose)
- Pneumonia
- Pulse absent
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Unresponsive to stimuli
- Acute respiratory failure
- Asthenia (weakness)
- Blood lactic acid increased
- Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
- Cardiomegaly (increased size of heart than normal)
male:
- Cardiac failure congestive
What are the common drug interactions of Ventavis and Restasis, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Pain in extremity
40-49:
n/a
50-59:
- Food allergy
- Swelling face
60+:
- Epistaxis (bleed from the nose)
- Abdominal pain
- Unresponsive to stimuli
- Acute respiratory failure
- Anaemia (lack of blood)
- Asthenia (weakness)
- Blood lactic acid increased
- Cardiac failure congestive
- Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
- Cardiomegaly (increased size of heart than normal)
What are the existing conditions these people have? *
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 12 people, 75.00%
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 18.75%
* Approximation only. Some reports may have incomplete information.
Do you take Ventavis and Restasis?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Ventavis and Restasis:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ventavis:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Restasis:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ventavis and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Restasis and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on iloprost and cyclosporine (the active ingredients of Ventavis and Restasis, respectively), and Ventavis and Restasis (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Alphagan and Fall for Women aged 50-59 - 13 seconds ago
- Could Lansoprazole cause Body Height Decreased? - 13 seconds ago
- Blood Albumin Decreased and drugs of ingredients of somatropin recombinant - 27 seconds ago
- Trileptal and Infection for Women aged 50-59 - 36 seconds ago
- How effective is Cimzia for Crohn'S Disease? - 47 seconds ago
- Levoxyl and Celiac Disease - Sprue for Women aged 60+ - 48 seconds ago
- Levoxyl and Coeliac Disease for Women aged 60+ - 48 seconds ago
- Levoxyl and Celiac Disease for Women aged 60+ - 48 seconds ago
- Levoxyl and Sprue for Women aged 60+ - 49 seconds ago
- Levoxyl and Nontropical Sprue for Women aged 60+ - 49 seconds ago